X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-27 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $9.44 | -77,136 | 139,771 | -36% | -$727,853 | |||||
2024-03-26 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.55 | -21,438 | 143,524 | -13% | -$204,733 | ||||||
2024-03-25 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.10 | -22,163 | 164,962 | -12% | -$201,683 | ||||||
2024-03-06 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $9.02 | -1,664 | 187,125 | -1% | -$15,009 | ||||||
2024-02-06 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $8.03 | -5,665 | 188,789 | -3% | -$45,490 | ||||||
2023-12-07 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $4.80 | -5,000 | 194,454 | -3% | -$24,000 | ||||||
| DM | 2022-07-26 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $2.17 | -3,725 | 46,510 | -7% | -$8,079 | |||||
2022-07-19 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.86 | -2,725 | 49,235 | -5% | -$5,069 | ||||||
2022-07-12 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.84 | -2,725 | 51,960 | -5% | -$5,014 | ||||||
2022-07-05 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.63 | -2,725 | 54,685 | -5% | -$4,442 | ||||||
| DM | 2022-06-28 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $1.84 | -3,725 | 57,410 | -6% | -$6,870 | |||||
2022-06-21 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.31 | -2,725 | 60,135 | -4% | -$3,570 | ||||||
2022-06-14 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.21 | -2,725 | 62,860 | -4% | -$3,297 | ||||||
2022-06-07 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.30 | -2,725 | 65,585 | -4% | -$3,543 | ||||||
| DM | 2022-05-31 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $1.43 | -3,725 | 68,310 | -5% | -$5,311 | |||||
2022-05-24 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.54 | -2,725 | 71,035 | -4% | -$4,197 | ||||||
2022-05-17 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.55 | -2,725 | 73,760 | -4% | -$4,224 | ||||||
2022-05-10 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $1.97 | -2,725 | 76,485 | -3% | -$5,368 | ||||||
| D | 2022-05-04 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $2.17 | -1,000 | 79,210 | -1% | -$2,170 | |||||
2022-05-03 | SERA | Boniface John J. | Chief Scientific Officer | S - Sale | $2.17 | -2,725 | 79,210 | -3% | -$5,913 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |